Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,354,999 papers from all fields of science
Search
Sign In
Create Free Account
Human Platelet Antigens-2 (HPA-2)
Known as:
HPA-2
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
HPA-2:Type:Pt:Bld:Nom
PLATELET GROUPS--Ko SYSTEM
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Human platelet antigen genotyping of platelet donors in southern Brazil
Jóice Merzoni
,
I. Fagundes
,
+8 authors
L. F. Jobim
International Journal of Immunogenetics
2015
Corpus ID: 22361057
Human platelet antigens (HPA) are immunogenic structures that result from single nucleotide polymorphisms (SNPs) leading to…
Expand
2013
2013
Molecular HPA genotyping by microarray in Brazilian blood donors
F. Conti
,
G. Bertrand
,
+6 authors
J. Kutner
Transfusion
2013
Corpus ID: 22419425
Human platelet antigens (HPA) polymorphisms may cause HPA alloimmunization, platelet (PLT) refractoriness, fetomaternal…
Expand
Review
2011
Review
2011
EGF signaling comes of age: Promotion of healthy aging in C. elegans
Simon Yu
,
M. Driscoll
Experimental Gerontology
2011
Corpus ID: 36368729
2010
2010
Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease
Nesrine Abboud
,
Lakdhar Ghazouani
,
+6 authors
T. Mahjoub
Journal of Thrombosis and Thrombolysis
2010
Corpus ID: 13398519
The contribution of human platelet antigen (HPA)-1 (GPIIb/IIIa), HPA-2 (GPIb/IX), and HPA-3 (GPIIb/IIIa) polymorphisms to the…
Expand
2008
2008
Polymorphisms of the human platelet alloantigens HPA‐1, HPA‐2, HPA‐3, and HPA‐4 in ischemic stroke
S. Saidi
,
T. Mahjoub
,
L. B. Slamia
,
Sofyan B. Ammou
,
A. Al-Subaie
,
W. Almawi
American journal of hematology/oncology
2008
Corpus ID: 24426981
Polymorphism in human platelet antigen (HPA)‐1 and HPA‐3 (GPIIb/IIIa), HPA‐2 (GPIb/IX), HPA‐4 (GPIIIa), and HPA‐5 (GPIa/IIa) was…
Expand
2003
2003
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
H. Ulrichts
,
K. Vanhoorelbeke
,
+4 authors
H. Deckmyn
Arteriosclerosis, Thrombosis and Vascular Biology
2003
Corpus ID: 26098914
OBJECTIVE Glycoprotein (GP) Ibalpha is the functionally dominant subunit of the platelet GPIb-IX-V receptor complex. The N…
Expand
2000
2000
Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor.
C. Li
,
S. Garner
,
J. Davies
,
P. Smethurst
,
M. Wardell
,
W. Ouwehand
Blood
2000
Corpus ID: 34564103
Glycoprotein (GP) Ibalpha is the functionally dominant subunit of the platelet GPIb-IX-V receptor complex, with the von…
Expand
1999
1999
Incompatibility for CD31 and human platelet antigens and acute graft‐versus‐host disease after bone marrow transplantation
C. Balduini
,
P. Noris
,
+7 authors
F. Locatelli
British Journal of Haematology
1999
Corpus ID: 44329019
Bone marrow transplantation (BMT) is often complicated by acute graft‐versus‐host disease (aGVHD). In patients transplanted with…
Expand
1997
1997
Gene Frequencies of the HPA‐1 and HPA‐2 Platelet Antigen Alleles among the Amerindians
D. Covas
,
M. Delgado
,
M. M. Zeitune
,
J. Guerreiro
,
S. Santos
,
M. Zago
Vox Sanguinis
1997
Corpus ID: 45587064
Background and objectives: Platelet‐specific alloantigens are important in neonatal alloimmune thrombocytopenia, posttransfusion…
Expand
1994
1994
Association of a Variable Number of Tandem Repeats (VNTR) in Glycoprotein Ibα and HPA-2 Alloantigens
S.
,
Simsek
,
+6 authors
V. Borne
Thrombosis and Haemostasis
1994
Corpus ID: 21500259
Summary The human platelet alloantigen HPA-2 (Koa/Kob) system is involved in two clinical syndromes, neonatal alloimmune…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE